Literature DB >> 6333248

Generation of an interleukin-I-like lymphocyte-stimulating factor at inflammatory sites: correlation with the infiltration of polymorphonuclear leucocytes.

K Goto, S Nakamura, F Goto, M Yoshinaga.   

Abstract

Using a mouse thymocyte co-stimulation assay, we demonstrated thymocyte-stimulating activity in murine peritoneal fluid obtained from the early stage (3 to 9 h) of casein-induced inflammation. This early inflammatory stage coincided with the time at which an influx of polymorphonuclear leucocytes (PMN) into the inflamed site was observed. Similar thymocyte-stimulating activity was produced in vitro by PMN purified from 4-h peritoneal exudate but not by purified PMN obtained at a later stage (24 h) of the inflammation. The inflammatory factor was interleukin (IL)-I-like; it was devoid of IL-2 activity when tested with IL-2-dependent cells. It could stimulate murine thymocytes to produce IL-2. On a Sephadex G-75 column, the factor was eluted between the molecular sizes of 10 000 and 30 000; its peak activity was at 21 000. The factor mainly consisted of two (pI 6.5 and pI 5.0) iso-electrophoretically different factors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333248      PMCID: PMC2040859     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  13 in total

1.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

2.  Lymphocyte-activating factor. I. Generation and physicochemical characterization.

Authors:  J S Economou; H S Shin
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

3.  Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (Interleukin 1).

Authors:  S B Mizel
Journal:  Mol Immunol       Date:  1980-05       Impact factor: 4.407

4.  Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages.

Authors:  P A Murphy; P L Simon; W F Willoughby
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

5.  The in vivo quantitation and kinetics of rabbit neutrophil leukocyte accumulation in the skin in response to chemotactic agents and Escherichia coli.

Authors:  A C Issekutz; H Z Movat
Journal:  Lab Invest       Date:  1980-03       Impact factor: 5.662

6.  Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen.

Authors:  L J Rosenwasser; C A Dinarello; A S Rosenthal
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

7.  Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.

Authors:  J Watson; S Gillis; J Marbrook; D Mochizuki; K A Smith
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

8.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

9.  Failure of rabbit neutrophils to secrete endogenous pyrogen when stimulated with staphylococci.

Authors:  D F Hanson; P A Murphy; B E Windle
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

10.  In vitro stimulation of lymphocytes by neutral proteinases from human polymorphonuclear leukocyte granules.

Authors:  T L Vischer; U Bretz; M Baggiolini
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  10 in total

1.  Enhanced oxidative burst without interleukin 1 production by normal human polymorphonuclear leukocytes primed with muramyl dipeptides.

Authors:  C Jupin; M Parant; L Chedid; C Damais
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

2.  Biosynthesis of interleukin-I beta at inflammatory site in rabbits: kinetics and producing cells.

Authors:  F Goto; K Goto; S Mori; S Ohkawara; M Yoshinaga
Journal:  Br J Exp Pathol       Date:  1989-12

3.  Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms.

Authors:  L H Faccioli; G E Souza; F Q Cunha; S Poole; S H Ferreira
Journal:  Agents Actions       Date:  1990-06

4.  Correlation of leukocyte interleukin-1 production with the stimulation of prostaglandin and tissue factor synthesis by human umbilical vein endothelial cells.

Authors:  R G Schaub; C J Dunn; M R Deibel; A E Berger; D Wunderlich; W E Fleming
Journal:  Agents Actions       Date:  1990-08

5.  Inflammatory and immunological responses in skin and peripheral lymph of sheep following intracutaneous injection of Staphylococcus aureus.

Authors:  R L Kerlin; D L Watson; I G Colditz
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

6.  Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein biosynthesis and neutrophil CD18 antigen expression in vivo.

Authors:  M Rampart; T J Williams
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

7.  Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice.

Authors:  M Perretti; E Solito; L Parente
Journal:  Agents Actions       Date:  1992-01

8.  Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.

Authors:  M Ligumsky; P L Simon; F Karmeli; D Rachmilewitz
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

9.  Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody.

Authors:  L Feng; Y Xia; T Yoshimura; C B Wilson
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Purification and partial primary sequence of a chemotactic protein for polymorphonuclear leukocytes derived from human lung giant cell carcinoma LU65C cells.

Authors:  K Suzuki; H Miyasaka; H Ota; Y Yamakawa; M Tagawa; A Kuramoto; S Mizuno
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.